Company: GIFLF
Filing Date: 2025-06-12
Form Type: 6-K
Source: 0001104659-25-058641
Chunk: 1

Company: Grifols SA
Filing Date: 2025-06-12
Form: 6-K
Chunk 1
---
 6, 2025 at 24:00 hours (local time in Frankfurt am Main) / 18:00 hours (local
time in New York).

The Delisting Offer has been accepted
for a total of 416,922 ordinary shares of Biotest and a total of 3,002,804 non-voting preferred shares of Biotest. Regarding the ordinary
shares, this corresponds to a stake of approximately 2.11% of all issued voting ordinary shares and approximately 1.05% of Biotest's share
capital. Regarding the non-voting preferred shares, this corresponds to a stake of approximately 15.18% of all issued non-voting preferred
shares of Biotest, as well as approximately 7.59% of Biotest's share capital. In this regard, Grifols will pay a total of € 108,011,766
as the offer price.

As a result of the Delisting Offer,
Grifols will hold, directly and indirectly through its subsidiary Grifols Biotest Holdings GmbH, 99.25% of all issued voting ordinary
shares and 61.40% of all issued non-voting preferred shares of Biotest.

As described in more detail in Section
12.5 of the Offer Document, the settlement of the Delisting Offer and the payment of the corresponding Offer Price for the Biotest shares
submitted for sale will be made no later than the fourth business day following this communication, in accordance with the terms and conditions
of the Offer Document. The settlement of the Delisting Offer is expected to take place on June 16, 2025.

Furthermore, it is also reported
that Biotest has received the formal notification of the approval of the application for the revocation of the admission of its shares
to trading by the Frankfurt Stock Exchange. The delisting is effective as of June 6, 2025. As from that date, Biotest shares are no longer
traded on the Frankfurt Stock Exchange.

In Barcelona, June 11, 2025

| Nuria Martín Barnés                 |
| Secretary of the Board of Directors |

<div align='center'>3

SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

| Grifols, S.A. |                   |